James Sutherland, MD
Rheumatology · Mechanicsville, VANPI 1467458232
Payments from drug & device makers
Across 250 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$991
- Amgen$622
- UCB, Inc.$469
- Pfizer$437
- Lilly USA, LLC$369
- Johnson & Johnson$314
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,594100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $991 |
| Amgen(2 entities) | 31 | $622 |
| UCB, Inc. | 29 | $469 |
| Pfizer | 28 | $437 |
| Lilly USA, LLC | 18 | $369 |
| Johnson & Johnson | 16 | $314 |
| Novartis | 12 | $259 |
| E.r. Squibb & Sons, L.L.C. | 17 | $243 |
| Mallinckrodt Hospital Products Inc. | 7 | $196 |
| GSK | 8 | $123 |
| Genentech USA, Inc. | 6 | $98 |
| Bristol Myers Squibb | 5 | $83 |
| AstraZeneca | 3 | $53 |
| Sandoz | 2 | $43 |
| Radius Health, Inc. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Boehringer Ingelheim | 1 | $31 |
| Sanofi | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Biodelivery Sciences International, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Octapharma USA, Inc. | 1 | $15 |
| Organon | 1 | $8 |
How this compares
$4,594 in reported general payments places this provider in the 55th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $2,423 |
| MethotrexateMethotrexate Sodium | 72 | $1,662 |
| Oxycodone Hcl | 45 | $1,320 |
| Gabapentin | 41 | $975 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $930 |
| Hydroxychloroquine Sulfate | 20 | $680 |
| Prednisone | 71 | $511 |
| Trazodone Hcl | 19 | $319 |
| Diclofenac Sodium | 13 | $310 |
| Tramadol Hcl | 20 | $304 |
| Pregabalin | 11 | $253 |
| Allopurinol | 14 | $225 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Mechanicsville
- Lindsay HoltzMechanicsville$10K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
- Kristi MizelleNewport News$1.2M
- Phillip KempfArlington$467K
- Adegbenga BankoleRoanoke$355K
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
- Michael CannonVirginia Beach$145K
- Phong NguyenReston$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.